Related Experiment Video

Updated: Sep 29, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

A role of fatty acid oxidation in cardiac hypertrophy

R Bressler1, S Goldman

  • 1Department of Medicine, University of Arizona Health Sciences Center, Tucson.

Cardioscience
|September 1, 1993
PubMed

Insights

Inducing myocardial hypertrophy with a carnitine palmitoyl transferase I inhibitor helped prevent pathological heart dilation after a large myocardial infarction in rats. This intervention improved systolic function and reduced heart enlargement.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Myocardial infarction (MI) can lead to pathological cardiac remodeling, including left ventricular (LV) dilation, increasing risks of arrhythmias, heart failure, and sudden death.
  • Infarctions exceeding 20% of the LV induce minimal compensatory hypertrophy, leading to increased filling pressures and dilation.
  • Inadequate myocardial hypertrophy post-MI is hypothesized to drive progressive LV dilation.

Purpose of the Study:

  • To investigate if inducing additional myocardial hypertrophy using 2-tetradecylglycidic acid (TDGA) can prevent pathological LV dilation after a large MI in rats.
  • To assess the effects of TDGA-induced hypertrophy on cardiac function following a significant myocardial infarction.

Main Methods:

  • Rats underwent a large myocardial infarction (50% of LV).
  • Experimental groups received oral administration of 2-tetradecylglycidic acid, an inhibitor of carnitine palmitoyl transferase I, for 10 days post-infarction.
  • Hemodynamic parameters, including peak developed LV pressure, LV end-diastolic volume, and stroke volume, were measured.

Main Results:

  • TDGA treatment induced myocardial hypertrophy in both control and infarcted rats.
  • Infarcted rats treated with TDGA exhibited increased peak developed LV pressure and reduced LV end-diastolic volumes compared to untreated infarcted rats.
  • Stroke volume was maintained in the TDGA-treated infarcted group.

Conclusions:

  • Pharmacological induction of myocardial hypertrophy using a long-chain fatty acid oxidation inhibitor (TDGA) mitigated LV dilation post-large MI.
  • This approach demonstrated beneficial effects on systolic function, suggesting a potential therapeutic strategy for post-MI cardiac remodeling.

More Related Videos

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart12:24

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart

Published on: September 28, 2016

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Related Concept Videos

Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...